|Datasheet||Specific References||Reviews||Related Products||Protocols|
|ORF Clone of Homo sapiens tripeptidyl peptidase I DNA.|
|CLN2, GIG1, LPIC, TPP-1, TPP1|
|Identical with the Gene Bank Ref. ID sequence.|
|Whatman FTA elute card (Cat: WB120410) contains 5-10 μg of plasmid.|
|The Whatman FTA elute card can be stored at room temperature for three months under dry condition.|
The pGEM-T is 3kb in length, and contains the amplicin resistance gene, conferring selection of the plasmid in E. coli, and the ori site which is the bacterial origin of replication. The plasmid has multiple cloning sites as shown below. The coding sequence was inserted by TA cloning. Many E. coli strains are suitable for the propagation of this vector including JM109, DH5α and TOP10.
The coding sequence can be easily obtained by digesting the vector with proper restriction enzyme(s). The coding sequence can also be amplified by PCR with M13 primers, or primer pair SP6 and T7.
|Human TPP1 Gene cDNA Clone (full-length ORF Clone), expression ready, FLAG-tagged||HG13619-G-F|
|Human TPP1 Gene cDNA Clone (full-length ORF Clone), expression ready, His-tagged||HG13619-G-H|
|Human TPP1 Gene cDNA Clone (full-length ORF Clone), expression ready, Myc-tagged||HG13619-G-M|
|Human TPP1 Gene cDNA Clone (full-length ORF Clone), expression ready, untagged||HG13619-G-N|
|Human TPP1 Gene cDNA Clone (full-length ORF Clone), expression ready, HA-tagged||HG13619-G-Y|
|Product name||Product name|
Tripeptidyl-peptidase 1 (TPP1 / CLN2) is a member of the sedolisin family of serine proteases. The protease functions in the lysosome to cleave N-terminal tripeptides from substrates, and has weaker endopeptidase activity. It is synthesized as a catalytically-inactive enzyme which is activated and auto-proteolyzed upon acidification. TPP1 / CLN2 May act as a non-specific lysosomal peptidase which generates tripeptides from the breakdown products produced by lysosomal proteinases. Defects in TPP1 / CLN2 are the cause of neuronal ceroid lipofuscinosis type 2 (CLN2), a form of neuronal ceroid lipofuscinosis which is associated with the failure to degrade specific neuropeptides and a subunit of ATP synthase in the lysosome. Neuronal ceroid lipofuscinoses are progressive neurodegenerative, lysosomal storage diseases characterized by intracellular accumulation of autofluorescent liposomal material, and clinically by seizures, dementia, visual loss, and/or cerebral atrophy.